Keyphrases
RAD51
100%
Homologous Recombination
65%
DNA Replication
58%
HEXIM1
41%
BET Inhibition
41%
USP50
41%
Gap Formation
41%
PrimPol
41%
Bulky DNA Adducts
41%
PARP2
41%
SMARCAL1
41%
PARP Inhibitor (PARPi)
41%
Protein Targeting
41%
Adenovirus
41%
Base Excision Repair
41%
Replication Fork
41%
Cellular DNA
41%
DNA2
41%
53BP1
41%
DNA Polymerase
41%
RecQ Helicase
41%
BRCA1, BRCA2
41%
Synthetic Lethality
41%
RAD52
32%
BET Inhibitor
30%
Nuclease
21%
Replication Stress
20%
DNA Damage Response
20%
Stalled Replication Fork
19%
Bulky Adduct
17%
Gap Filling
16%
Breast Cancer Susceptibility Gene 1 (BRCA1)
16%
Single-stranded DNA (ssDNA)
16%
E1B-55K
14%
Viral Replication
14%
MRE11
14%
Helicase
13%
Helicase Activity
13%
Flap Endonuclease 1 (FEN1)
13%
RECQL4
13%
Nuclease Activity
13%
Mammalian Cells
11%
Experimental Cancer
10%
BET Bromodomain Protein
10%
RNA Synthesis
10%
Transcription-replication Conflicts
10%
Clinical Application
10%
Bromodomain-containing Protein 4 (BRD4)
10%
Cancer Drugs
10%
Clinical Trials
10%
Biochemistry, Genetics and Molecular Biology
Homologous Recombination
63%
DNA Synthesis
59%
RAD51
58%
Nuclease
49%
Base Excision Repair
41%
Helicase
41%
RecQ Helicase
41%
DNA Polymerase theta
41%
PARP2
41%
PARP1
41%
SMARCAL1
41%
Adenoviridae
41%
DNA Adduct
41%
Transcription
41%
BRCA1
41%
RAD52
32%
RECQL4
20%
DNA Damage Response
16%
Genotyping
16%
Polymerase
16%
Virus Replication
14%
DNA Damage
11%
Telomere Homeostasis
10%
Protease
10%
Ubiquitin
10%
Cell Survival
10%
GC Rich Sequence
10%
Hydroxycarbamide
10%
Genetics
10%
Telomere
10%
Bromodomain
8%
BRD4
8%
Clinical Trial
8%
P-TEFb
8%
RNA Synthesis
8%
Carcinogenesis
8%
Cyclin-Dependent Kinase
7%
Sister Chromatid Exchange
5%
Genetic Recombination
5%
Primase
5%
DNA RNA Hybridization
5%
Single-Strand DNA Break
5%